Sowell Financial Services LLC Oramed Pharmaceuticals Inc. Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$8.34 - $14.59 $14,653 - $25,634	-1,757 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$4.22 - $11.33 $2,232 - $5,993	529 Added 43.08%	1,757 $19,000
Q4 2020 Jan 13, 2021	BUY	$2.48 - $4.64 $74 - $139	30 Added 2.5%	1,228 $5,000
Q3 2020 Nov 12, 2020	BUY	$2.58 - $4.16 $425 - $686	165 Added 15.97%	1,198 $3,000
Q2 2020 Aug 13, 2020	BUY	$2.87 - $4.12 $177 - $255	62 Added 6.39%	1,033 $4,000

Q1 2020 May 12, 2020	BUY	$2.6 - $5.5 $837 - $1,771	322 Added 49.61%	971 $3,000
Q4 2019 Feb 07, 2020	BUY	$2.43 - $5.74 $1,266 - $2,990	521 Added 407.03%	649 $3,000
Q3 2019 Nov 14, 2019	BUY	$2.88 - $3.96 $368 - $506	128 New	128 $0

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $100M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.